Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach

Area of Science:

• Oncology
• Hematology
• Health Services Research

Background:

• Financial hardship frequently affects patients diagnosed with hematologic malignancies and their families.
• This financial strain is linked to poorer health outcomes and survival rates.
• Contributing factors include healthcare expenses, elevated living costs, income poverty, and insufficient wealth.

Purpose of the Study:

• To highlight the significant public health issue of financial hardship in hematologic malignancy patients.
• To advocate for a multidisciplinary, team-based strategy to address this challenge.
• To identify roles for various stakeholders in mitigating financial toxicity.

Main Methods:

• Literature review and synthesis of existing knowledge on financial hardship in hematologic malignancy.
• Analysis of the multifaceted nature of financial burden.
• Conceptual framework for a multidisciplinary approach.

Main Results:

• Hematologic malignancy diagnosis and treatment often lead to substantial financial hardship.
• Key contributors include direct medical costs, indirect living expenses, and income loss.
• A collaborative approach is essential for effective intervention.

Conclusions:

• Hematologists and oncologists can help by aligning treatments with patient goals and managing symptoms affecting employment.
• Social workers and financial navigators play a crucial role in screening and connecting patients with resources.
• Policy changes and further research are needed to address systemic issues and prevent financial hardship, ultimately improving patient survival and quality of life.